Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration

NCT02328209 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Exudative Age-related Macular Degeneration

Interventions

DRUG: ranibizumab

Sponsor

Mie University